Paper Details

  1. Home
  2. Paper Details

Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.

Author: CitromeL

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Inhaled loxapine was effective and tolerable for the treatment of agitation associated with schizophrenia or bipolar disorder. Inhaled loxapine was superior to placebo in reducing agitation, with a number needed to treat of 3-4. The most common adverse event was dysgeusia, with a number needed to harm of 10-12.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To describe the efficacy and safety of inhaled loxapine, a new formulation of an older antipsychotic being developed for the treatment of agitation associated with schizophrenia or bipolar disorder. DATA SOURCES: A literature search was conducted by querying http://www.pubmed.gov, http:/...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1742-1241.2010.02615.x

データ提供：米国国立医学図書館（NLM）

Inhaled Loxapine: A New Oasis for Agitation

This research is like a journey through a desert oasis, seeking relief for those experiencing agitation associated with schizophrenia or bipolar disorder. The study explores the efficacy and safety of inhaled loxapine, a novel formulation of an older antipsychotic, in treating agitation. It's a promising development, offering a potentially more convenient and tolerable treatment option.

A New Pathway to Relief: Inhaled Loxapine Offers Promise

The study found that inhaled loxapine effectively reduced agitation in patients with schizophrenia and bipolar disorder. The medication showed a rapid onset of action and was well-tolerated, with minimal side effects. This research offers a potential breakthrough in the management of agitation, a debilitating symptom that can significantly impact quality of life.

A Camel's Perspective on Mental Health

Mental health challenges can be like a scorching desert heat, causing immense distress. This research offers a glimmer of hope for those struggling with agitation, providing a potentially more effective and tolerable treatment option. It's a reminder that innovation and research are crucial in addressing the needs of those living with mental health conditions.

Dr. Camel's Conclusion

This research is a refreshing oasis in the desert of mental health challenges. The development of inhaled loxapine offers a potential solution for those struggling with agitation. It's a reminder that the search for new and better treatments for mental health conditions continues, offering hope and relief for those in need.

Date :
  1. Date Completed 2011-12-22
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

21199198

DOI: Digital Object Identifier

10.1111/j.1742-1241.2010.02615.x

Related Literature

Article Analysis
・Side Effects of loxapine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.